Your partial permission to access Pkulaw.com expires on . Upon expiry your account can still be used, but some access will be limited.

Renew
Home > English > Legal News > Full Text
Hits Focused   English 中文
Copy Full Text Download Favorite Operation
  • Format:
  • View:

China adds 119 drugs to medicare reimbursement list

[CLI Code] CLI.N.16748054(EN) 

BEIJING, Dec. 28 (Xinhua) -- China has included 119 more kinds of drugs in its national medical insurance reimbursement list, delivering greater price cuts and benefiting more people, the National Healthcare Security Administration (NHSA) said at a press conference Monday.
Ninety-six of the new additions to the list are exclusive drugs that offer lower prices through negotiation and 16 were newly put on the market this year, the NHSA said.
Altogether, a record number of 162 drugs on the list were negotiated for price reduction. A deal was reached for 119 of the drugs, with their prices dropping an average of 50.64 percent.
The inclusions also helped expand the scope of reimbursement to cover more diseases including COVID-19. So far, all the medicines listed in China's latest diagnosis and treatment scheme for COVID-19 have been added to the reimbursement list, the NHSA said.
China currently has 2,800 kinds of medicines on the medicare reimbursement list, including 1,374 traditional Chinese patent medicines.

© Pkulaw (www.pkulaw.com) provides various professional solutions in such fields as legal information, law knowledge and legal software. Pkulaw provides you with abundant reference materials. When you invoke articles of laws and regulations, please check them with the standard texts.
You are welcome to view all our products and services. Pkulaw Express:How to quickly find information you need? What are the new features of Pkulaw V6?

Scan QR Code and Read on Mobile

智能检索

Welcome to V6

We will provide better legal search services for you

Back to V5 Still in V6